{"data":{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:30181805", "kind": "science-record", "revision": 8, "content_hash": "sha256:57a02dfd003e7b93cd601d9cd5d51466dab048864961289fe445ba1e42605193", "created_at": "2026-11-01T15:40:37Z", "updated_at": "2026-11-01T22:00:01Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Identification of key pathways and genes in response to trastuzumab treatment in breast cancer using bioinformatics analysis.", "doi": "10.18632/oncotarget.24605", "pmid": "30181805", "authors": ["Fanxin Zeng", "Jiangping Fu", "Fang Hu", "Yani Tang", "Xiangdong Fang", "Fanwei Zeng", "Yanpeng Chu"], "journal": "Oncotarget", "year": 2018, "abstract": "Breast cancer (BC) is one of the leading causes of death among women worldwide. The gene expression profile GSE22358 was downloaded from the Gene Expression Omnibus (GEO) database, which included 154 operable early-stage breast cancer samples treated with neoadjuvant capecitabine plus docetaxel, with (34) or without trastuzumab (120), to identify gene signatures during trastuzumab treatment and uncover their potential mechanisms. The gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes pathway (KEGG) enrichment analyses were performed, and a protein-protein interaction (PPI) network of the differentially expressed genes (DEGs) was constructed by Cytoscape software. There were 2284 DEGs, including 1231 up-regulated genes enriched in DNA replication, protein N-linked glycosylation via asparagine, and response to toxic substances, while 1053 down-regulated genes were enriched in axon guidance, protein localization to plasma membrane, protein stabilization, and protein glycosylation. Eight hub genes were identified from the PPI network, including GSK3B, RAC1, PXN, ERBB2, HSP90AA1, FGF2, PIK3R1 and RAC2. Our experimental results showed that GSK3B was also highly expressed in breast cancer tissues and was associated with poor survival, as was β-catenin. In conclusion, the present study indicated that the identified DEGs and hub genes further our understanding of the molecular mechanisms underlying trastuzumab treatment in BC and highlighted GSK3B, which might be used as a molecular target for the treatment of BC.", "claims": [{"id": "claim-method", "statement": "We used a classical t test to identify DEGs with defined a P value cutoff of < 0.05 as statistically significant.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:30181805", "locator": "sections[10] \"Identification of DEGs\" paragraph 2", "quote": "We used a classical t test to identify DEGs with defined a P value cutoff of < 0.05 as statistically significant."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The gene expression profiles of GSE22358 were downloaded from the GEO database. GSE22358, which was based on the Agilent GPL5325 platform (Agilent, CA, USA), was submitted by Gluck et al. The GSE22358 dataset contained 154 operable early-stage BC samples receiving neoadjuvant capecitabine plus docetaxel, with (34) or without trastuzumab (120). The raw data files used for the analysis included TXT files (Agilent platform).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:30181805", "locator": "sections[9] \"Microarray data\" paragraph 2", "quote": "The gene expression profiles of GSE22358 were downloaded from the GEO database."}, {"asset": "source:pmid:30181805", "locator": "sections[9] \"Microarray data\" paragraph 2", "quote": "GSE22358, which was based on the Agilent GPL5325 platform (Agilent, CA, USA), was submitted by Gluck et al."}, {"asset": "source:pmid:30181805", "locator": "sections[9] \"Microarray data\" paragraph 2", "quote": "The GSE22358 dataset contained 154 operable early-stage BC samples receiving neoadjuvant capecitabine plus docetaxel, with (34) or without trastuzumab (120)."}, {"asset": "source:pmid:30181805", "locator": "sections[10] \"Identification of DEGs\" paragraph 2", "quote": "The raw data files used for the analysis included TXT files (Agilent platform)."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:30181805"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE22358"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE22358"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:30181805", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.18632/oncotarget.24605", "sha256": "sha256:e37d4d7a04d69ce6f9e9c69d96313b5686c14ef3168aa655bc7cfaba911dc37d", "bytes": 39080, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.18632/oncotarget.24605", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC6114942", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE22358", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE22358", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE22358", "version": null, "note": "The gene expression profiles of GSE22358 were downloaded from the GEO database. GSE22358, which was based on the Agilent GPL5325 platform (Agilent, CA, USA), was submitted by Gluck et al. The GSE22358 dataset contained 154 operable early-stage BC samples receiving neoadjuvant capecitabine plus docetaxel, with (34) or without trastuzumab (120). The raw data files used for the analysis included TXT files (Agilent platform).", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The gene expression profiles of GSE22358 were downloaded from the GEO database. GSE22358, which was based on the Agilent GPL5325 platform (Agilent, CA, USA), was submitted by Gluck et al. The GSE22358 dataset contained 154 operable early-stage BC samples receiving neoadjuvant capecitabine plus docetaxel, with (34) or without trastuzumab (120). The raw data files used for the analysis included TXT files (Agilent platform).", "access_statement_kind": "repository_route_statement", "sample_accessions": ["GSM508516", "GSM508517", "GSM508518", "GSM508519", "GSM508520", "GSM508521", "GSM508522", "GSM508524", "GSM508525", "GSM508526", "GSM508527", "GSM508544", "GSM508545", "GSM508546", "GSM508547", "GSM508548", "GSM508549", "GSM508551", "GSM508552", "GSM508553", "GSM508554", "GSM508555", "GSM508556", "GSM508557", "GSM508558", "GSM508559", "GSM508560", "GSM508561", "GSM508562", "GSM508563", "GSM508564", "GSM508565", "GSM508566", "GSM508567", "GSM508568", "GSM508569", "GSM508570", "GSM508571", "GSM508572", "GSM508573", "GSM508574", "GSM508575", "GSM508576", "GSM508577", "GSM508578", "GSM508579", "GSM508580", "GSM508581", "GSM508582", "GSM508583", "GSM508584", "GSM508585", "GSM508586", "GSM508587", "GSM508588", "GSM508589", "GSM508590", "GSM508591", "GSM508592", "GSM508630", "GSM508631", "GSM508632", "GSM508633", "GSM508634", "GSM508635", "GSM508636", "GSM508637", "GSM508638", "GSM508639", "GSM508640", "GSM508641", "GSM508642", "GSM508643", "GSM508644", "GSM508645", "GSM508646", "GSM508647", "GSM508648", "GSM508649", "GSM508650", "GSM508651", "GSM508652", "GSM508653", "GSM508654", "GSM508655", "GSM508656", "GSM508657", "GSM508658", "GSM508659", "GSM508660", "GSM508662", "GSM508663", "GSM508664", "GSM508665", "GSM508666", "GSM508667", "GSM508668", "GSM508669", "GSM508670", "GSM508671", "GSM508672", "GSM508673", "GSM508674", "GSM508675", "GSM508676", "GSM508677", "GSM508678", "GSM508679", "GSM508680", "GSM508681", "GSM508682", "GSM508736", "GSM508737", "GSM508738", "GSM508739", "GSM508740", "GSM508741", "GSM508742", "GSM508743", "GSM508744", "GSM508745", "GSM508746", "GSM508747", "GSM508748", "GSM508749", "GSM508750", "GSM508751", "GSM508752", "GSM508753", "GSM508754", "GSM508755", "GSM508756", "GSM508757", "GSM508758", "GSM508759", "GSM508760", "GSM508761", "GSM508762", "GSM508763", "GSM508764", "GSM508765", "GSM508766", "GSM508767", "GSM508768", "GSM508769", "GSM508770", "GSM508771", "GSM508772", "GSM508773", "GSM508774", "GSM508775", "GSM508776", "GSM517353", "GSM517354", "GSM556167", "GSM556168", "GSM556169", "GSM556170"], "sample_count": 158, "group_sizes": null, "group_sizes_basis": null, "platform": "5325", "taxon": "Homo sapiens", "title": "Clinical and Pathologic Response of the Primary Tumor in Women Receiving Neoadjuvant Docetaxel-Capecitabine (+/- Trastuzumab) Chemotherapy", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:30181805:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:04b77696e2651771da7cdfc81dbeef361dea776eb3f325e86517fa7e9377f447", "bytes": 4549, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[3]/table-wrap[1]#T1", "version": null, "note": "Gene ontology analysis of differentially expressed genes associated with trastuzumab", "structure": {"pmcid": "PMC6114942", "section_index": 3, "section_title": "Identification of DEGs", "row_count": 61, "column_count": 6}, "table": {"label": "Table 1", "caption": "Gene ontology analysis of differentially expressed genes associated with trastuzumab", "rows": [["Expression", "Category", "Term", "Count", "%", "P-Value"], ["Up-regulated", "GOTERM_BP_DIRECT", "DNA replication", "25", "2", "8.80E-05"], ["GOTERM_BP_DIRECT", "protein N-linked glycosylation via asparagine", "11", "0.9", "1.80E-04"], ["GOTERM_BP_DIRECT", "response to toxic substance", "16", "1.3", "1.10E-03"], ["GOTERM_BP_DIRECT", "mRNA 3’-end processing", "11", "0.9", "1.20E-03"], ["GOTERM_BP_DIRECT", "anaphase-promoting complex-dependent catabolic process", "14", "1.1", "1.70E-03"], ["GOTERM_BP_DIRECT", "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest", "12", "1", "2.00E-03"], ["GOTERM_BP_DIRECT", "cell division", "38", "3.1", "2.00E-03"], ["GOTERM_BP_DIRECT", "mRNA splicing, via spliceosome", "27", "2.2", "2.70E-03"], ["GOTERM_BP_DIRECT", "regulation of signal transduction by p53 class mediator", "18", "1.5", "2.80E-03"], ["GOTERM_BP_DIRECT", "DNA repair", "28", "2.3", "2.90E-03"], ["GOTERM_MF_DIRECT", "DNA polymerase binding", "6", "0.5", "4.00E-04"], ["GOTERM_MF_DIRECT", "ATPase activity", "25", "2", "9.80E-04"], ["GOTERM_MF_DIRECT", "protein binding", "449", "36.5", "2.50E-03"], ["GOTERM_MF_DIRECT", "microtubule binding", "25", "2", "4.70E-03"], ["GOTERM_MF_DIRECT", "poly(A) RNA binding", "96", "7.8", "6.50E-03"], ["GOTERM_MF_DIRECT", "damaged DNA binding", "11", "0.9", "6.70E-03"], ["GOTERM_MF_DIRECT", "histone deacetylase binding", "15", "1.2", "8.60E-03"], ["GOTERM_MF_DIRECT", "helicase activity", "13", "1.1", "1.00E-02"], ["GOTERM_MF_DIRECT", "sulfuric ester hydrolase activity", "5", "0.4", "1.40E-02"], ["GOTERM_MF_DIRECT", "ATP binding", "120", "9.8", "1.50E-02"], ["GOTERM_CC_DIRECT", "nucleoplasm", "238", "19.3", "2.70E-07"], ["GOTERM_CC_DIRECT", "membrane", "181", "14.7", "1.00E-04"], ["GOTERM_CC_DIRECT", "melanosome", "18", "1.5", "1.80E-04"], ["GOTERM_CC_DIRECT", "nucleus", "395", "32.1", "3.00E-04"], ["GOTERM_CC_DIRECT", "intracellular membrane-bounded organelle", "56", "4.6", "5.50E-04"], ["GOTERM_CC_DIRECT", "cytosol", "256", "20.8", "8.50E-04"], ["GOTERM_CC_DIRECT", "kinetochore", "14", "1.1", "1.20E-03"], ["GOTERM_CC_DIRECT", "nucleolus", "76", "6.2", "2.70E-03"], ["GOTERM_CC_DIRECT", "proteasome complex", "11", "0.9", "4.50E-03"], ["GOTERM_CC_DIRECT", "condensed chromosome kinetochore", "13", "1.1", "7.40E-03"], ["", "GOTERM_BP_DIRECT", "axon guidance", "20", "1.9", "1.40E-03"], ["GOTERM_BP_DIRECT", "protein localization to plasma membrane", "11", "1", "1.70E-03"], ["GOTERM_BP_DIRECT", "protein stabilization", "17", "1.6", "3.00E-03"], ["GOTERM_BP_DIRECT", "protein glycosylation", "15", "1.4", "3.00E-03"], ["GOTERM_BP_DIRECT", "regulation of phosphatidylinositol 3-kinase signaling", "12", "1.1", "3.40E-03"], ["GOTERM_BP_DIRECT", "response to cocaine", "8", "0.8", "3.60E-03"], ["GOTERM_BP_DIRECT", "ERBB2 signaling pathway", "8", "0.8", "4.20E-03"], ["GOTERM_BP_DIRECT", "substrate adhesion-dependent cell spreading", "8", "0.8", "4.20E-03"], ["GOTERM_BP_DIRECT", "centrosome localization", "5", "0.5", "4.30E-03"], ["GOTERM_BP_DIRECT", "O-glycan processing", "10", "0.9", "5.20E-03"], ["GOTERM_MF_DIRECT", "solute:proton symporter activity", "3", "0.3", "8.40E-03"], ["GOTERM_MF_DIRECT", "metallocarboxypeptidase activity", "6", "0.6", "1.40E-02"], ["GOTERM_MF_DIRECT", "ErbB-3 class receptor binding", "3", "0.3", "1.60E-02"], ["GOTERM_MF_DIRECT", "calcium-dependent protein binding", "9", "0.9", "1.60E-02"], ["GOTERM_MF_DIRECT", "protein tyrosine phosphatase activity", "12", "1.1", "1.90E-02"], ["Down-regulation", "GOTERM_MF_DIRECT", "receptor signaling protein activity", "7", "0.7", "2.00E-02"], ["", "GOTERM_MF_DIRECT", "protein phosphatase binding", "9", "0.9", "2.00E-02"], ["GOTERM_MF_DIRECT", "protein kinase binding", "31", "2.9", "2.20E-02"], ["", "GOTERM_MF_DIRECT", "zinc ion binding", "81", "7.7", "2.50E-02"], ["", "GOTERM_MF_DIRECT", "1-phosphatidylinositol-3-kinase activity", "7", "0.7", "2.70E-02"], ["", "GOTERM_CC_DIRECT", "Golgi membrane", "58", "5.5", "1.70E-05"], ["", "GOTERM_CC_DIRECT", "endoplasmic reticulum membrane", "77", "7.3", "2.50E-05"], ["", "GOTERM_CC_DIRECT", "membrane", "152", "14.4", "1.10E-03"], ["", "GOTERM_CC_DIRECT", "Golgi apparatus", "67", "6.4", "3.30E-03"], ["", "GOTERM_CC_DIRECT", "actin cytoskeleton", "22", "2.1", "8.50E-03"], ["", "GOTERM_CC_DIRECT", "cytoplasm", "317", "30.1", "1.10E-02"], ["", "GOTERM_CC_DIRECT", "mitochondrial membrane", "12", "1.1", "1.20E-02"], ["", "GOTERM_CC_DIRECT", "axon", "22", "2.1", "1.70E-02"], ["", "GOTERM_CC_DIRECT", "cis-Golgi network", "7", "0.7", "1.80E-02"], ["", "GOTERM_CC_DIRECT", "uropod", "4", "0.4", "1.90E-02"]], "row_count": 61, "column_count": 6, "numeric_cells": 186, "header_rows": 1, "locator": "section[3]/table-wrap[1]#T1"}}, {"id": "asset:table:pmid:30181805:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:b72b4557cd1b82aee2f3de2f0920b03091151c26060c1d083a9943449eaa1463", "bytes": 862, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[4]/table-wrap[1]#T2", "version": null, "note": "KEGG pathway analysis of differentially expressed genes associated with trastuzumab", "structure": {"pmcid": "PMC6114942", "section_index": 4, "section_title": "KEGG pathway analysis", "row_count": 11, "column_count": 5}, "table": {"label": "Table 2", "caption": "KEGG pathway analysis of differentially expressed genes associated with trastuzumab", "rows": [["Category", "KEEG Term", "Count", "%", "P-Value"], ["Down-regulation", "Proteoglycans in cancer", "23", "2.2", "1.40E-03"], ["ErbB signaling pathway", "13", "1.2", "2.80E-03"], ["Bacterial invasion of epithelial cells", "12", "1.1", "3.40E-03"], ["Insulin signaling pathway", "17", "1.6", "3.70E-03"], ["Neurotrophin signaling pathway", "15", "1.4", "6.00E-03"], ["Up-regulation", "Protein processing in endoplasmic reticulum", "27", "2.2", "1.10E-04"], ["Base excision repair", "8", "0.7", "6.90E-03"], ["Pentose and glucuronate interconversions", "8", "0.7", "1.10E-02"], ["Proteasome", "8", "0.7", "3.20E-02"], ["Ascorbate and aldarate metabolism", "6", "0.5", "3.70E-02"]], "row_count": 11, "column_count": 5, "numeric_cells": 30, "header_rows": 1, "locator": "section[4]/table-wrap[1]#T2"}}, {"id": "asset:table:pmid:30181805:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:04b77696e2651771da7cdfc81dbeef361dea776eb3f325e86517fa7e9377f447", "bytes": 4549, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[3]/table-wrap[1]#T1", "version": null, "note": "Gene ontology analysis of differentially expressed genes associated with trastuzumab", "structure": {"pmcid": "PMC6114942", "section_index": 10, "section_title": "Identification of DEGs", "row_count": 61, "column_count": 6}, "table": {"label": "Table 1", "caption": "Gene ontology analysis of differentially expressed genes associated with trastuzumab", "rows": [["Expression", "Category", "Term", "Count", "%", "P-Value"], ["Up-regulated", "GOTERM_BP_DIRECT", "DNA replication", "25", "2", "8.80E-05"], ["GOTERM_BP_DIRECT", "protein N-linked glycosylation via asparagine", "11", "0.9", "1.80E-04"], ["GOTERM_BP_DIRECT", "response to toxic substance", "16", "1.3", "1.10E-03"], ["GOTERM_BP_DIRECT", "mRNA 3’-end processing", "11", "0.9", "1.20E-03"], ["GOTERM_BP_DIRECT", "anaphase-promoting complex-dependent catabolic process", "14", "1.1", "1.70E-03"], ["GOTERM_BP_DIRECT", "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest", "12", "1", "2.00E-03"], ["GOTERM_BP_DIRECT", "cell division", "38", "3.1", "2.00E-03"], ["GOTERM_BP_DIRECT", "mRNA splicing, via spliceosome", "27", "2.2", "2.70E-03"], ["GOTERM_BP_DIRECT", "regulation of signal transduction by p53 class mediator", "18", "1.5", "2.80E-03"], ["GOTERM_BP_DIRECT", "DNA repair", "28", "2.3", "2.90E-03"], ["GOTERM_MF_DIRECT", "DNA polymerase binding", "6", "0.5", "4.00E-04"], ["GOTERM_MF_DIRECT", "ATPase activity", "25", "2", "9.80E-04"], ["GOTERM_MF_DIRECT", "protein binding", "449", "36.5", "2.50E-03"], ["GOTERM_MF_DIRECT", "microtubule binding", "25", "2", "4.70E-03"], ["GOTERM_MF_DIRECT", "poly(A) RNA binding", "96", "7.8", "6.50E-03"], ["GOTERM_MF_DIRECT", "damaged DNA binding", "11", "0.9", "6.70E-03"], ["GOTERM_MF_DIRECT", "histone deacetylase binding", "15", "1.2", "8.60E-03"], ["GOTERM_MF_DIRECT", "helicase activity", "13", "1.1", "1.00E-02"], ["GOTERM_MF_DIRECT", "sulfuric ester hydrolase activity", "5", "0.4", "1.40E-02"], ["GOTERM_MF_DIRECT", "ATP binding", "120", "9.8", "1.50E-02"], ["GOTERM_CC_DIRECT", "nucleoplasm", "238", "19.3", "2.70E-07"], ["GOTERM_CC_DIRECT", "membrane", "181", "14.7", "1.00E-04"], ["GOTERM_CC_DIRECT", "melanosome", "18", "1.5", "1.80E-04"], ["GOTERM_CC_DIRECT", "nucleus", "395", "32.1", "3.00E-04"], ["GOTERM_CC_DIRECT", "intracellular membrane-bounded organelle", "56", "4.6", "5.50E-04"], ["GOTERM_CC_DIRECT", "cytosol", "256", "20.8", "8.50E-04"], ["GOTERM_CC_DIRECT", "kinetochore", "14", "1.1", "1.20E-03"], ["GOTERM_CC_DIRECT", "nucleolus", "76", "6.2", "2.70E-03"], ["GOTERM_CC_DIRECT", "proteasome complex", "11", "0.9", "4.50E-03"], ["GOTERM_CC_DIRECT", "condensed chromosome kinetochore", "13", "1.1", "7.40E-03"], ["", "GOTERM_BP_DIRECT", "axon guidance", "20", "1.9", "1.40E-03"], ["GOTERM_BP_DIRECT", "protein localization to plasma membrane", "11", "1", "1.70E-03"], ["GOTERM_BP_DIRECT", "protein stabilization", "17", "1.6", "3.00E-03"], ["GOTERM_BP_DIRECT", "protein glycosylation", "15", "1.4", "3.00E-03"], ["GOTERM_BP_DIRECT", "regulation of phosphatidylinositol 3-kinase signaling", "12", "1.1", "3.40E-03"], ["GOTERM_BP_DIRECT", "response to cocaine", "8", "0.8", "3.60E-03"], ["GOTERM_BP_DIRECT", "ERBB2 signaling pathway", "8", "0.8", "4.20E-03"], ["GOTERM_BP_DIRECT", "substrate adhesion-dependent cell spreading", "8", "0.8", "4.20E-03"], ["GOTERM_BP_DIRECT", "centrosome localization", "5", "0.5", "4.30E-03"], ["GOTERM_BP_DIRECT", "O-glycan processing", "10", "0.9", "5.20E-03"], ["GOTERM_MF_DIRECT", "solute:proton symporter activity", "3", "0.3", "8.40E-03"], ["GOTERM_MF_DIRECT", "metallocarboxypeptidase activity", "6", "0.6", "1.40E-02"], ["GOTERM_MF_DIRECT", "ErbB-3 class receptor binding", "3", "0.3", "1.60E-02"], ["GOTERM_MF_DIRECT", "calcium-dependent protein binding", "9", "0.9", "1.60E-02"], ["GOTERM_MF_DIRECT", "protein tyrosine phosphatase activity", "12", "1.1", "1.90E-02"], ["Down-regulation", "GOTERM_MF_DIRECT", "receptor signaling protein activity", "7", "0.7", "2.00E-02"], ["", "GOTERM_MF_DIRECT", "protein phosphatase binding", "9", "0.9", "2.00E-02"], ["GOTERM_MF_DIRECT", "protein kinase binding", "31", "2.9", "2.20E-02"], ["", "GOTERM_MF_DIRECT", "zinc ion binding", "81", "7.7", "2.50E-02"], ["", "GOTERM_MF_DIRECT", "1-phosphatidylinositol-3-kinase activity", "7", "0.7", "2.70E-02"], ["", "GOTERM_CC_DIRECT", "Golgi membrane", "58", "5.5", "1.70E-05"], ["", "GOTERM_CC_DIRECT", "endoplasmic reticulum membrane", "77", "7.3", "2.50E-05"], ["", "GOTERM_CC_DIRECT", "membrane", "152", "14.4", "1.10E-03"], ["", "GOTERM_CC_DIRECT", "Golgi apparatus", "67", "6.4", "3.30E-03"], ["", "GOTERM_CC_DIRECT", "actin cytoskeleton", "22", "2.1", "8.50E-03"], ["", "GOTERM_CC_DIRECT", "cytoplasm", "317", "30.1", "1.10E-02"], ["", "GOTERM_CC_DIRECT", "mitochondrial membrane", "12", "1.1", "1.20E-02"], ["", "GOTERM_CC_DIRECT", "axon", "22", "2.1", "1.70E-02"], ["", "GOTERM_CC_DIRECT", "cis-Golgi network", "7", "0.7", "1.80E-02"], ["", "GOTERM_CC_DIRECT", "uropod", "4", "0.4", "1.90E-02"]], "row_count": 61, "column_count": 6, "numeric_cells": 186, "header_rows": 1, "locator": "section[3]/table-wrap[1]#T1"}}], "gaps": ["asset:data:geo:GSE22358 not downloaded", "asset:data:geo:GSE22358 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "network_analysis", "specific": "ppi_network", "label": "Network / pathway analysis", "dsl_operations": ["build_graph", "centrality_scores", "pathway_enrich"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["edge_list"], "evidence": {"score": 0.7, "band": "medium", "quote": "protein-protein interaction"}}, {"id": "method-2", "family": "network_analysis", "specific": "pathway_enrichment", "label": "Network / pathway analysis", "dsl_operations": ["pathway_enrich"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["edge_list"], "evidence": {"score": 0.8, "band": "high", "quote": "pathway enrichment"}}, {"id": "method-3", "family": null, "specific": null, "label": "classical t test", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "We used a classical t test to identify DEGs with defined a P value cutoff of < 0.05 as statistically significant."}}], "targets": [], "gaps": ["method.reader_named_unmapped"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["build_graph", "centrality_scores", "pathway_enrich"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: ppi_network."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE22358"], "resolved_accessions": ["GSE22358"], "statements": ["The gene expression profiles of GSE22358 were downloaded from the GEO database. GSE22358, which was based on the Agilent GPL5325 platform (Agilent, CA, USA), was submitted by Gluck et al. The GSE22358 dataset contained 154 operable early-stage BC samples receiving neoadjuvant capecitabine plus docetaxel, with (34) or without trastuzumab (120). The raw data files used for the analysis included TXT files (Agilent platform)."], "basis": "The paper names GSE22358 in Gene Expression Omnibus (GEO) database and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["build_graph", "centrality_scores", "pathway_enrich"], "assets": ["source:pmid:30181805", "data:geo:GSE22358", "asset:table:pmid:30181805:1", "asset:table:pmid:30181805:2", "asset:table:pmid:30181805:3"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE22358"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:12:12Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": null}, "calls": 3, "usage": {"prompt_tokens": 34133, "completion_tokens": 830, "cached_tokens": 784}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:30181805", "type": "paper", "label": "pmid:30181805"}, {"id": "source:pmid:30181805", "type": "manuscript", "label": "PMID 30181805 full text"}, {"id": "data:geo:GSE22358", "type": "dataset", "label": "GEO GSE22358"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:30181805", "type": "paper", "label": "pmid:30181805"}, {"id": "source:pmid:30181805", "type": "manuscript", "label": "PMID 30181805 full text"}, {"id": "data:geo:GSE22358", "type": "dataset", "label": "GEO GSE22358"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-30181805", "type": "extraction", "used": ["source:pmid:30181805"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE22358", "type": "accession_resolution", "used": ["data:geo:GSE22358"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:30181805", "parent_hash": "sha256:9802737b024ed9b3cbe332403c0ad7b324b4ebb4cefab414c7f2996a72094a70", "fork_of": null, "generation": 7}, "gaps": ["asset:data:geo:GSE22358 licence not read", "asset:data:geo:GSE22358 not downloaded", "execution.not_run", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "clinical_trial", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["4 operable early-stage breast cancer samples treated with neoadjuvant capecitabine plus docetaxel, with (34) or without trastuzumab (120), to identify gene signatur"], "order_basis": "paper_text_order:324", "id": "assay:1"}, {"role": "analysis", "definition_id": "network_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["build_graph", "centrality_scores", "pathway_enrich"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 0.7, "evidence": ["protein-protein interaction"], "order_basis": "consumes_earlier_output", "id": "assay:2"}]},"meta":{"api_version":"v1","automation_ladder_snapshot":"ba34b49490d9bfaf","automation_ladder_caveats":["Method extraction is rule-based and has no hand-judged accuracy sample. Evidence bands order textual support; method agreement intervals are null (n=0), never probabilities. Work-type validation does not validate methods.","Operation coverage describes only explicitly named methods. It does not prove a complete protocol, compatible parameters, successful compilation or re-execution. Unrecognised or ambiguous methods require review.","Data reachability is a textual accession or public-data statement. No dataset was downloaded or checked for access, completeness or licence.","Capabilities are planning states seeded from the dated equipment register. No bench ownership, completed quote or partner booking is inferred. Procurement counts are dependencies, not guaranteed replications or financial returns.","Tier and blocker counts are deterministic assessments of this corpus, not measured agreement. R3 is reserved for procurement; unresolved methods and data require human work (R4). The most restrictive axis wins, with capability, method, data as tie-breaks. Resolving one blocker can leave another at the same tier."],"engine":"corpus_engine","engine_provider":"rule_based_v1+lex99e1195c7d6f","run_id":"run-20261023T122449232913","source":"esearch","source_detail":"PubMed mirror biomed_pubmed (read-only)","run_status":"complete","imported_at":"2026-11-03T20:16:52+00:00","generated_at":"2026-11-04T02:50:53+00:00","total_papers":5529,"total_assays_tracked":29,"automatable_assay_families":6,"validated":true,"caveat_count":9,"blocking_caveats":5,"caveats":[{"code":"low_evidence_dominates","basis":["4,152 of 5,529 classifications (75.1%) matched no cue evidence and sit at the 0.05 floor.","34 of 230 data_only calls (14.8%) are in that group."],"claim":"Work type and confidence bands","gloss":"Most records were classified from their title and framing alone, with assay-cue coverage at zero.","detail":"Most classifications in this run rest on no matched evidence at all. At the evidence floor the work type comes from title framing and a fixed prior, not from anything in the paper, so the published work-type split should be read as a rough triage signal rather than a measured distribution. The impact is bounded but not removed: since 2026-10-23 the engine excludes floor-confidence records from the shortlist entirely and publishes them separately as held out, so the recommendation is unaffected even though the census is.","status":"unverified","severity":"high"},{"code":"runtime_is_modelled","basis":["Runtime is summed from published per-assay hour figures. Timing awaits the first executed replication.","4,407 of 5,529 records (79.7%) model to 0.00 hours because no assay was matched, which the ranking then reads as \"cheapest\".","0 of 10 shortlisted records carry a 0.00-hour estimate."],"claim":"Estimated replication runtime","gloss":"The hour figures are estimates built from assay mentions; timing awaits the first executed replication.","detail":"The hour figures are a cost model derived from the bench steps implied by each matched assay family. The first executed replication will supply measured timing. Records without an assay match currently receive a zero-hour model value.","status":"unverified","severity":"high"},{"code":"signal_score_without_citations","basis":["5,529 of 5,529 records (100.0%) have no citation count from the source metadata."],"claim":"Signal score","gloss":"The signal score uses publication-type weight because the mirror supplied zero citation counts.","detail":"The source supplied no citation counts for any record in this run, so the signal score is publication-type weight only. The citation term of the ranking is inert here, and the shortlist is ordered by publication type alone.","status":"unverified","severity":"high"},{"code":"abstract_absent","basis":["1,667 of 5,529 records (30.2%) carry no abstract at all."],"claim":"Evidence base for classification","gloss":"Some records contain a title and publication type only, defining the available classification evidence.","detail":"Where the mirror contains a title and publication types only, those fields define the classifier evidence. A methods section is required for fuller automated and human review.","status":"unverified","severity":"medium"},{"code":"classifier_agreement_measured","basis":["Published two-way decision agreement 77.7% (310 of 399 decidable records) from a stratified hand-check of 438 real records.","Three-way diagnostic agreement 73.9% (288 of 390 decidable records).","data_only agreement 75.2% (100 of 133 decidable).","48 record(s) could not be decided from title and abstract and were excluded from the denominator.","56 analysis-only records were published under another work type, so the data_only share is not an upper bound."],"claim":"Published automatable decision","gloss":"This figure has been checked against a human reading the same papers, so we know how often it is right.","detail":"The published automatable / not-automatable distribution comes from a rule-based classifier that was hand-checked against a fixed ground-truth definition. The agreement rates below are measured, not estimated. The three-way work type remains a diagnostic and is reported separately.","status":"measured","severity":"high"},{"code":"llm_comparison_not_measured","basis":["rule_based_v1+lex99e1195c7d6f produced 5,529 of 5,529 classifications.","Measured on 438 labelled records; these are RULE-BASED figures, not model results."],"claim":"Rule-based versus LLM agreement","gloss":"Every number here is the rule engine’s own. Model comparison begins when a working API credential is connected and measured.","detail":"The published two-way decision agreed with a human reading on 310 of 399 decidable records (77.7%). The diagnostic three-way label agreed on 288 of 390 decidable records (73.9%). Every percentage in this run belongs to the rule engine. Model comparison begins when a working API credential is connected and measured.","status":"not_measured","severity":"high"},{"code":"confidence_is_a_band","basis":["low band: 135 of 210 hand-judged records were correct, 64.3% [57.6, 70.5] (95% CI).","medium band: 80 of 104 hand-judged records were correct, 76.9% [68.0, 84.0] (95% CI).","high band: 73 of 76 hand-judged records were correct, 96.0% [89.0, 98.7] (95% CI).","A fitted calibrated probability was built, measured and withdrawn: it overstated held-out accuracy and reorders nothing."],"claim":"Confidence band and evidence score","gloss":"The confidence band carries a measured accuracy interval; 0.85 represents relative rank strength.","detail":"Confidence on this run is a BAND plus its measured accuracy interval. The number stored alongside each record is a monotone evidence score that orders records; 0.85 represents relative rank strength. A fitted probability was withdrawn after it overstated held-out accuracy. Threshold on the band.","status":"measured","severity":"medium"},{"code":"three_way_split_is_diagnostic","basis":["The corpus is published at the two-way decision: automatable or not-automatable. The three-way split (data_only / physical / mixed) is published as a diagnostic with its measured reliability attached, not as a claim, because the rule engine's `mixed` call cannot be defended.","The engine called 22 record(s) mixed; 10 matched the human judgement (45.5%, 95% CI 26.9-65.3).","The engine's `mixed` call is right on 10/22 hand-judged records (45.5%, 95% CI 26.9%-65.3%); a constant `physical` guess scores 36.4%.","The engine's `mixed` call does not reliably beat a constant `physical` guess on the hand-judged records it labels mixed.","The sign of that difference flips between two independent samples, so the three-way refinement is not demonstrably informative.","The mixed stratum contributes a disproportionate share of errors relative to its size.","At title-only depth the physical/mixed split collapses: a title says that work was done, not whether it was also analysed."],"claim":"The published decision is two-way","gloss":"The three-way split is shown for diagnosis only. The published split is two ways.","detail":"Count and filter the corpus on automatable versus not-automatable. The data_only / physical / mixed split remains an internal engine diagnostic because the mixed call has lower measured reliability.","status":"measured","severity":"medium"},{"code":"automatable_flag_unproven","basis":["6 of 29 assay families are marked automatable now: meta_analysis, machine_learning, survival_analysis, pca, molecular_docking, differential_expression.","The flag is a rule over assay family and work type; validation begins with the first executed replication.","It inherits the 75.2% data_only agreement rate, because the flag requires the record to be analysis-only."],"claim":"Automatable now","gloss":"This flag marks assay families the rules classify as data-only. The first executed replication will validate it.","detail":"This flag marks families the rules consider replicable from data alone. Its validity depends on the analysis-only classification and will be measured through an executed replication.","status":"unverified","severity":"medium"}],"confidence_policy":"band_with_measured_interval","confidence_contract":{"policy":"band_with_measured_interval","summary":"Confidence is reported as a BAND with a measured accuracy interval. The raw evidence score supplies monotone ordering. A fitted point estimate was withdrawn after it overstated held-out accuracy.","evidence_score":"A monotone evidence score in [0,1] built from cue mass, axis separation and text coverage. Use it to order records. Interpret 0.85 as relative rank strength.","confidence_band":"low | medium | high. Consumers threshold on this value.","band_accuracy":"Wilson 95% interval on the measured agreement of the hand-judged records in this band.","calibrated_confidence":"WITHDRAWN. Reintroduction requires held-out evidence demonstrating reliable estimates across every bin."},"band_accuracy":{"low":{"n":210,"low":0.576,"band":"low","high":0.7046,"agree":135,"accuracy":0.6429},"high":{"n":76,"low":0.8903,"band":"high","high":0.9865,"agree":73,"accuracy":0.9605},"medium":{"n":104,"low":0.6795,"band":"medium","high":0.8397,"agree":80,"accuracy":0.7692}},"provider":"rule_based_v1+lex99e1195c7d6f","lexicon_id":"99e1195c7d6f","contract_published_at":"2026-10-23T12:25:29.022232+00:00","confidence_is_band":true,"confidence_is_probability":false,"decision_taxonomy":"two_way","decidable_fraction_two_way":0.8854,"decidable_fraction_two_way_low":0.8565,"decidable_fraction_two_way_high":0.9143,"decidable_fraction_three_way":0.8586,"decidable_fraction_three_way_low":0.8287,"decidable_fraction_three_way_high":0.8884,"decidable_population":5529,"validation_sample_size":438,"three_way_cost_fraction":0.0268,"three_way_cost_records":148,"decision_counts":{"automatable":230,"not_automatable":5299},"decision_split":{"automatable":{"count":230,"share":0.04159884246699222},"not_automatable":{"count":5299,"share":0.9584011575330078}},"diagnostic_work_type_counts":{"mixed":24,"physical":5275,"data_only":230}}}